Fourteen laboratories participated in an exteraal quality control survey (EQCS) for antithyroglobulin-and antirnicrosomal-antibody determination. Seventeen frozen serum samples from individuals suffering from various thyroid diseases were dispatched by mail. Different test Systems were used by the participants including the haemagglutination test, radioimmunoassay (RIA), enzyme immunoassay (ELISA) and immunofluorescence test. The different test results of each participant were sized and could be compared by giving place numbers to each test result. Inter-laboratory quality control was performed by evaluation of a rank correlation coefficient. There was close agreement between the haemagglutination test results of antimicrosomal antibody determination with different test kits, and these tests showed good precision. Antithyroglobulin antibody titers from the two haemagglutination test-kits used, however, were not directly comparable. When sized by place numbers, antithyroglobulin antibody results from haemagglutination test, RIA and ELISA were in close agreement. The least correspondence was shown by the immunofluorescence test, in the antithyroglobulin antibody determination.
Introduction
Autoantibodies against various components of the thyroid gland have gained in importance, especially with reference to the aetiology (l -4) and diagnosis (5, 6) of various diseases of the thyroid gland. This increasing importance is due not least to more sensitive test Systems, which were developed during the last few years. The following applications of autoantibody determination have attracted special attention:
1) Differentiation between Graves* disease and autonomous adenomata and multifocal aütonomy, respectively; 2) follow-up of Graves* disease under medical treatment; 3) investigation of the role that autoantibodies may play in the differentiation between immunogenic thyroid disorders and simple endemic goiter (7); 4) investigation bf the natural history pf Hashimoro's disease with special regard to the development of hypothyroidism (8) .
Basically four different Systems are available for the determination of antithyroglobulin-and antimicrosomal-antibody: haemagglutination tests, radio-ligand-assays, enzyme immunoassays and finally immunofluorescence tests. The aim of this first external quality control survey was to determine whether the results of these different determinations are comparable. The survey was initiated by the German Endocrine Society, Thyroid Section. Fourteen German laboratories took part, some of them using more than one of the methods cited above.
Materials and Methods

Samples
Serum samples were drawn from 17 different patients with various diseases of the thyroid (tab. 1). It should be noted that the diagnoses were made according to clinical and functional criteria only, i.e. none of the antibodies to be tested underlay the diagnosis given in table l, except in Hashimoto*s disease (serum no. 3, 6, 16). The frozen serum samples were dispatched by mail, and the laboratories participating only knew the numbers of the serum samples.
Evaluation
Determination of antithyroglobulin antibodies
The following test Systems were used:
1) Haemagglutination test (Fujizoki distributed by Mast): 6 participants.
2) Haemagglutination test (Wellcome): 5 participants.
3) Radioligand assay (CIS/IDW): 3 participants. In view of the different methodologies (and the fact that the results were qualitative, semiquantitative or quantitative) a stanr dardized evaluation of the data was extremely difficult. Therefore we evaluated the results obtained by immunofluorescence tests separately ffom those obtained by haemagglutination tests. In addition, we tried to obtain an overall evaluation äs follpws: The different test results of each participant were sized arid a place number was given to each test result. Furthermore a rank correlation analysis (according to Speärman (9)) was applied to the ranks obtained from the test results for evaluation of inter-laboratory quality control.
Distribution of place numbers
The results obtained by each of the participants using their special methöd were sized and numbered; i.e. place number l was given to the highest values of antithyroglobulin antibody and so forth. If the same result was reported more than once, the appröpriate place number was given to each of these results, omitting the foU lowing place numbers. An example: Participant no. 2 obtained the highest antithyroglobulin antibody titer (1:25600) from sample no. 5 and 6; these received place number l, place no. 2 was omitted. The next lower titer (1:6400) was obtained from sample no. 3, which received place no. 3 and so forth. The negative results were evaluated separately: To each negative result place nö. 17 was given.
Distribution of ranks (used in rank correlation analysis)
Basically the distribution of ranks was done äs described above. The treatment of ties, however, was different: The rank given to equal results was computed äs the mean value of the ranks given to each of the equal results. In the example above the rank 1.5 (= (l+2)/2) was given to the two highest results. The same methöd was also applied to negative results. If, for example, four negative results were reported, to each of the^se results rank 15.5 (= Tab. 1. Characterization of samples.
Sample Diagnosis* no. (14+15 +16+17)/4) was given. Theoretically if 17 equal results had been obtained from one laboratory, rank 9 would have been given to each of them. A rank correlation analysis (9) was done with the 17 results of each participant. The reference quantities R$ were computed using the following formula:
ry: rank given to results of participant j for sample i;
i.e. the mean rank of participants for a particular sample was taken s reference quantity. The rank correlation coefficient TJ of participant j was computed by 17 6 Σ (ΓΗ In this way, an inter-laboratory comparison of the results was possible.
Results obtained by the haemagglutination test were evaluated searately from those obtained by the immunofluorescence test. Furthermore rank correlation analysis was done s described above.
Results
Antithyroglobulin antibodies
Haemagglutination test
The absolute antibody titers obtained by the two different test kits (Fujizoki, Wellcome) could not be compared. We therefore set the highest titer obtained by the Fujizoki (1:409600) equal to the highest titer obtained by the Wellcome kit (1:5120). The next lower titers were treated in the same way and so on. As one rnay see in figure l the results obtained by the two different test kits can be compared by this method fairly well. There is, however, one remarkable difference: The samples with very low titers are assessed s negative rnore often by the Wellcome kit than by the kit from Fujizoki. The results obtained by haemagglutination test did not depend on the two thyroglobulin concentrations (100 μ §/1, 300 μg/l), which were added to the samples 13 to produce samples 14 and 17.
Immunofluorescence test
The immunofluorescence test naturally gives less differentiation. Figure 2 shows that 14 out of the 17 samples were determined either positive or negative by the different participants. The results of samle 13 and 17 demonstrate the dependence on the high thyroglobulin concentration of the heterologous immunofluorescence tests. The concentration antithyroglobulin antibody in sample 17 is assessed s negative by two participants, whereas sample 13 is assessed s positive by all four participants. the participants yielded identical results, exeept for Evaluation of the place numbers sample NQS ?? g and 9 Jhe ^^ of these three Place numbers were distributed to each result resamples show the greatest differences: whereas gardless of whetHer it was determined by RIA, ELIabout half the participants ssessed these samples s SA, immunofluorescence test or haemagglutination negative, the rest ssessed these samples s positive, test (see above). Figure 3 shows that the majority of even markedly positive. Rank correlation analysis (Spearman) High rank correlation coefficients are yielded by the results of the haemagglutination tests, except for participant no. 9. A slightly lower rank correlation coefficient was yielded by radioimmunological methods, immunofluorescence tests giving the lowest (tab. 2).
Antimicrosomal antibodies
Haemagglutination lest
The titers obtained by haemagglutination test Wellcome are directly comparable to those obtained by haemagglutination test Fujizoki. The coincidence is fairly good (fig. 4) , except for the results from samples 6, 8 and 9 which were assessed äs markedly positive by haemagglutination test Fujizoki, whereas by haemagglutination test Wellcome the results were more often assessed äs negative.
Immunofluorescence test
The resülts obtained by immunofluorescence test coincide fairly well (except for two samples which are assessed äs negative äs well äs positive). The correspondence of these results was markedly better, compared with the immunofluorescence test results of the antithyroglobulin antibodies ( fig. 5 ).
Tab. 2. Rank correlation coefficient for antithyroglobulin antibody (all participants). If r| ^ 0.564 there is no linear correlation between the ranks of participant no. i and the mean values of all ranks (Rj, see formula no. 1).
Test Systems
Haemagglutination test Fujizoki Wellcome
Radioimmunoassay
IDW.CIS Serono
Own method (ELISA)
Partie-Rankcoripant relation no. coefficient 
Rank correlation analysis
The rank correl iion coefficients (tab. 3) of the participants using haemagglutination test are all markedly high. Though the coefficients of those participants using immunofluorescence test are lower they are still significant on the 1% leVel. The rank correlation coefficient was best in haemagglutination test kits; worse but still significant coefficients were obtained with immunofluorescence test kits. The use of the rank correlation analysis, however, needs some further explaiiations:
1) The method used by most of the participants is haemagglutination test (11 paftieijpants), whereas 7 participants used radioimmunologicai methods and only 4 immunofluorescence tests. It is obvious that the mean value of the ranks distributed to each of the results is biased by the method with the highest number of participants (i.e. haemagglutination test), Therefore the very high rank correlation coefficients of these participants are mainly due to the fact that they belong to the strongest group, because the mean value of ranks served äs the reference quantity in the correlation analysis.
2) Rank correlation coefficients can only serve äs a rough method to check the inter-laboratory comparability or deviation. It would be wrong to conclude that the results yielded by one participant are correct just because they show a high correlation coefficient. Furthermore, in external quality control surveys for assays without a reference method the mean value of the majority of the participants is not necessarily the correct result of the parameter under investigation.
It seems to be important to us that there is no interference of antithyroglobulin antibody in antimicrosomal antibody assays and vice versa. This is demonstrated by samples no. 2, 7,11,16 with high positive antimicrosomal antibody and negative antithyroglobulin antibody titers and sample no. 6 with high antithyroglobulin antibody titer and low (or even negative) antithyroglobulin antibody titer respectively.
In spite of these encouraging findings there is still room for improvements, especially in antithyroglobulin antibody test kits. It is desirable to achieve a better standardization in order to be able to compare the results obtained by different test kits. This would be possible, if RIA or ELISA for antithyroglobulin antibody (10) and antimicrosomal antibody (11) were used more widely, and international Standards wefe available to calibrate the different assay Systems.
